Toctino® Pregnancy Prevention Programme (PPP) and other Materials

 
 

This page is intended for patients

Toctino® (alitretinoin), distributed by Basilea Pharmaceuticals Ltd., is licensed in the United Kingdom as an oral treatment for patients suffering from severe chronic hand eczema that does not respond to potent topical corticosteroid therapy.

Toctino® (alitretinoin) is a naturally occurring, physiologic derivative of vitamin A and belongs to the well studied family of retinoids, which are all teratogens (known to cause birth defects); therefore, Toctino® (alitretinoin) is strictly contraindicated in women of child-bearing potential unless strict pregnancy testing and contraception is followed before, during and one month after cessation of treatment.

The product information provided on this site should not be used to diagnose, treat or advise regarding diseases. It does not replace the advice of a medical professional, who should be consulted for further information.

Please also read the Toctino Patient information leaflet (also available in your pack of Toctino) and the Toctino patient booklet if you have already been prescribed Toctino® (alitretinoin).
 
For further information, please contact our Medical Information team:
 
Medical Information
Basilea Pharmaceuticals Ltd.
 
T: +44 1 483 790023
F: +44 1 483 505345

General Disclaimers

The information on this site is provided "as is" without any warranties, expressed or implied. In particular, Basilea Pharmaceutica Ltd. and/or its subsidiaries ("Basilea") make no representation or warranty that the information contained on this site will be timely, complete or error-free. To the extent permitted by applicable laws, Basilea accepts no liability whatsoever in respect of any loss, damage or expenses arising from your use of this site or the unavailability of this site.

Applicable Laws

This site contains information about pharmaceutical products, treatments and therapies, which may or may not be available in other countries. Each country has specific laws, regulations and medical practices governing the communication of medical or other information on the Internet. Nothing in this site should be viewed as a solicitation or promotion of any particular pharmaceutical product, treatment or therapy, which is not authorized, by the laws and regulations of the country where the reader resides, or as a promotion or advertisement of any pharmaceutical products or services.

Health Information

This site contains information on medical and health-related topics. This information is not meant to be a substitute for the advice provided by your own doctor or other medical professional. You should not use this information for diagnosing a health problem or disease but always consult your own doctor.

Links to Other Web Sites

Basilea can direct you to external web sites. Basilea does not own these sites. Basilea does not necessarily endorse and is not responsible for the content of any offsite pages or any other sites linked to these sites. Use of linked sites that are not owned or operated by Basilea is at your own risk and Basilea will not be liable for any loss, damage or expenses, which you suffer or incur as a result of your use of such sites.